Journal Mobile Options
Table of Contents
Vol. 50, No. 5, 1998
Issue release date: November 1998
Horm Res 1998;50:276–283

Longitudinal Analysis of Maternal Serum Leptin Levels during Pregnancy, at Birth and Up To Six Weeks after Birth: Relation to Body Mass Index, Skinfolds, Sex Steroids and Umbilical Cord Blood Leptin Levels

Schubring C. · Englaro P. · Siebler T. · Blum W.F. · Demirakca T. · Kratzsch J. · Kiess W.
a Evangelisches Krankenhaus, Giessen; b Children’s Hospital, University of Leipzig; c Institute of Clinical Chemistry and Pathobiochemistry, University of Leipzig; d Lilly Deutschland GmbH, Bad Homburg, and Children’s Hospital, University of Giessen, Germany, and e Istituto di Semeiotica Medica, University of Padova, Italy

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Leptin is an important regulator of body fat mass and energy expenditure during adult life. The mechanisms by which maternal and fetal weight are regulated during pregnancy are poorly understood. In order to gain more insight into a potential role of leptin during gestation, a prospective, longitudinal study was carried out to measure leptin concentrations in maternal serum of 29 healthy women during pregnancy up to 6 weeks after birth and also in umbilical cord blood of their newborns. Leptin concentrations were measured using a specific RIA. In addition, estradiol, testosterone, and sex hormone binding globulin were determined using commercially available RIAs. The mothers’ skinfolds were determined at four sites using a Holtain caliper.

Leptin levels increased continuously during pregnancy and reached 25.8 ± 14.7 ng/ml at 38–40 weeks. At birth, leptin concentrations were 23.5 ± 15.4 ng/ml. Three days after delivery a significant decrease of leptin levels to 10.6 ± 6.0 ng/ml was observed. Six weeks after birth the leptin concentration in maternal serum was 13.8 ± 8.6 ng/ml. At birth, maternal serum levels were significantly higher than levels in cord blood and did not correlate with leptin levels in cord blood or neonatal weight. Furthermore, leptin levels did not correlate with maternal sex steroids and sex hormone binding globulin levels. At 6–8 weeks of pregnancy, maternal leptin serum levels correlated significantly with BMI (r = 0.81). The correlation coefficients (leptin vs. BMI) dropped with increasing gestational age and at birth only a poor correlation persisted (r = 0.50). Six weeks after birth there was again a high correlation between leptin levels in maternal serum and BMI (r = 0.76). Subscapular skinfold thickness was correlated to leptin concentrations in maternal serum during the whole period of the investigation.

In conclusion, maternal leptin levels continuously increased from 6–8 weeks up to 38–40 weeks of pregnancy. Maternal leptin levels decreased dramatically after birth. Six weeks after delivery, leptin levels were comparable to the values measured at the beginning of pregnancy. We hypothesize that leptin might play an important role during pregnancy and fetal development.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Campbell S, Soothill P: Detection and management of intrauterine growth retardation: A British approach; in Chervenak FA, Isaacson GC, Campbell S (eds): Ultrasound in Obstetrics and Gynecology. Boston, Little, Brown, 1993, vol 2, pp 1432–1435.
  2. Harding JE, Charlton V: Experimental nutritional supplementation for intrauterine growth retardation; in Harrison M, Golbus MS, Filly RA (eds): The Unborn Patient. Philadelphia, Saunders, 1991, pp 598–609.
  3. Friedman JM: The alphabet of weight control. Nature 1997;385:119–120.
  4. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425–432.
  5. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse ob protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546–549.
  6. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight in ob/ob mice. Science 1995;269:540–543.
  7. Lindpainter K: Finding an obesity gene: A tale of mice and man. N Engl J Med 1995;332:679–680.
  8. De Vos P, Saladin R, Auwerx J, Staels B: Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 1995;270:15958–15961.
  9. Lönqvist F, Arner P, Nordfors L, Schalling M: Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1995;1:950–953.
  10. Considine RV, Sinha MK, Heiman ML: Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292–295.
  11. Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, Marco C, Caro JF: Nocturnal rise of leptin in lean, obese, and non-insulin dependent diabetes mellitus subjects. J Clin Invest 1996;97:1344–1347.
  12. Hamilton BS, Paglia D, Kwan AYM, Deitel M: Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1995;1:953–956.
  13. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O’Rahilly S: Congenital leptin deficiency is associated with severe early onset obesity in humans. Nature 1997;387:903–908.
  14. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP: Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996;84:491–495.
  15. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, MacKellar W, Rosteck PR, Schoner B, Smith D, Tinsley FC, Zhang XY, Heiman M: The role of neuropeptide Y in antiobesity action of the obese gene product. Nature 1995;377:530–532.
  16. Blum WF, Kiess W, Rascher W (eds): Leptin – The Voice of Adipose Tissue. Heidelberg, Johann Ambrosius Barth Verlag, Edition J&J, 1997.
  17. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwern J: Transient increase in obese gene expression after food intake or insulin administration. Nature 1995;377:527–529.
  18. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543–546.
  19. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1:1155–1161.
  20. Butte NF, Hopkinson JM, Nicolson MA: Leptin in human reproduction: Serum leptin levels in pregnant and lactating women. J Clin Endocrinol Metab 1997;82:585–589.
  21. Schubring C, Kiess W, Englaro P, Rascher W, Dötsch J, Hanitsch S, Attanasio A, Blum WF: Leptin concentrations in amniotic fluid, venous and arterial cord blood and maternal serum: High leptin synthesis in the fetus and inverse correlation with placental weight. J Clin Endocrinol Metab 1997;82:1480–1483.
  22. Kiess W, Blum WF, Aubert M: Leptin, puberty and reproductive function: Lessons from animal studies and observations in humans. Eur J Endocrinol 1998;138:26–29.
  23. Blum WF, Englaro P, Hanitsch S, Juul A, Hertel TN, Müller J, Skakkebaek NE, Birkett M, Heiman M, Attanasio A, Kiess W, Rascher W: Plasma leptin levels in healthy children and adolescents: Dependence on body mass index, body fat mass, gender, pubertal stage and testosterone. J Clin Endocrinol Metab 1997;82:2904–2910.
  24. Hassink SG, de Lancey E, Sheslow DV, Smith-Kirwin SM, O’Connor DM, Considine RV: Placental leptin: An important new growth factor in intrauterine and neonatal development? Pediatrics 1997;100:124.
  25. Sagawa N, Mori T, Masuzaki H, Ogawa Y, Nakao K: Leptin production by hydatidiform mole. Lancet 1997;350:1518–1519.
  26. Senaris R, Garcia-Caballero T, Casabiell X, Gallego R, Castro R, Considine RV, Dieguez C, Casanueva FF: Synthesis of leptin in human placenta. Endocrinology 1997;138:4501–4504.
  27. Jockenhovel F, Blum WF, Vogel E: Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. J Clin Endocrinol Metab 1997;82:2510–2513.
  28. Wabitsch M, Blum WF, Muche R, Teller M, Rascher W: Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J Clin Invest 1997;100:808–813.
  29. Palmert MR, Radovick S, Boepple PA: The impact of reversible gonadal sex steroid suppression on serum leptin concentrations in children with central precocious puberty. J Clin Endocrinol Metab 1998;83:1091–1096.
  30. Schubring C: Temperature regulation in healthy and resuscitated newborns immediately after birth. J Perinat Med 1986;14:27–33.

    External Resources

  31. Tome MA, Lage M, Camina JP, Garcia-Mayor RV, Dieguez C, Casanueva FF: Sex-based differences in serum leptin concentrations from umbilical cord blood at delivery. Eur J Endocrinol 1997;137:655–658.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50